Anusha Thumma | Pharmaceutical Sciences| Best Researcher Award

Posted on by ScienceFather

Dr. Anusha Thumma | Pharmaceutical Sciences | Best Researcher Award

scientist at nova southeastern university, United States

Dr. Anusha Thumma holds a Ph.D. in Pharmaceutical Sciences and specializes in drug formulation, abuse-deterrent technologies, inhalation products, and vaccine adjuvants. With expertise in HPLC, qPCR, ELISA, DSC, and flow cytometry, she ensures regulatory compliance with FDA, ICH, GMP, and GLP standards. She has worked as an Associate Scientist at Lupin Pharmaceuticals, an R&D Scientist at US Pharma LTD, and an Associate Professor at Radex Regulatory Affairs. Her research includes mRNA vaccine lipid nanoparticles and opioid abuse-deterrent formulations. She excels in project management, data analysis (Minitab), and cross-functional collaboration.

Publication Profile

Orcid

🎓 Education

Dr. Anusha Thumma holds a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from Nova Southeastern University, USA (2023), where her dissertation focused on Abuse-Deterrent Composites: A Multi-Angle Approach. She earned her Master of Pharmacy (MPharm) from Osmania University, India (2013), specializing in Formulation and Characterization of Imiquimod Multiple Emulsion as a Novel Vaccine Delivery System. Her academic journey began with a Bachelor of Pharmacy (BPharm) from Kakatiya University, India (2011). With a strong foundation in pharmaceutical sciences, her research contributions span drug formulation, regulatory affairs, and vaccine development. 💊🔬

🏆 Academic Excellence & Professional Achievements

Dr. Anusha Thumma has been recognized with multiple prestigious scholarships and grants for her outstanding academic and research contributions. She received a fully funded PhD scholarship and a PhD Scholar Stipend from Nova Southeastern University, USA, along with the President’s Faculty Research and Development Grant and HPD Research Grant for her research excellence. She also secured fully funded scholarships for her Master’s (Osmania University) and Bachelor’s (Kakatiya University) degrees in India. Additionally, she holds a Professional Diploma in Regulatory Affairs (USA), is a Registered Pharmacist (India), and has attended webinars on drug discovery. 📜🎓💊

 

🔬 Research Focus Areas

Dr. Anusha Thumma’s research primarily focuses on environmental remediation 🌱, pharmaceutical sciences 💊, and drug abuse potential 🧪. She has made significant contributions to water purification by exploring biochar-based adsorption for removing heavy metals (cadmium, zinc, arsenic) and dyes from polluted water. Her expertise extends to pharmaceutical formulations, particularly in abuse-deterrent drug delivery systems. Additionally, she investigates the toxicity and abuse potential of fentanyl analogues. Her interdisciplinary work integrates biopolymer-based cryostructures, advancing biomedical and pharmaceutical applications. Through her research, she aims to enhance sustainable environmental solutions and safer pharmaceutical formulations. 🌍🔬💧

Publication Top Notes

  • Adsorptive removal of arsenic from drinking water using KOH-modified sewage sludge-derived biochar

  • Exploring the efficiency of sodium alginate beads and Cedrus deodara sawdust for adsorptive removal of crystal violet dye

  • Advances in cryostructures and their applications in biomedical and pharmaceutical products

  • Abuse potential of fentanyl and fentanyl analogues

  • Removal of cadmium and zinc from water using sewage sludge-derived biochar

  • Potential of easily available low-cost raw cotton for the elimination of methylene blue dye from polluted water

Vahideh Mohammadzadeh | Pharmacology Award | Best Researcher Award

Posted on by ScienceFather

Dr. Vahideh Mohammadzadeh | Pharmacology Award | Best Researcher Award

Dr. Vahideh Mohammadzadeh, mashhad university of medical science, Iran

Dr. Vahideh Mohammadzadeh is a Ph.D. student in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research focuses on innovative drug delivery systems like nanoliposomes for treating cancer and eye diseases. With expertise in nanoformulations (liposome, micelle, polymer), she conducts in-vitro assays and specializes in MTT assay and HPLC. Her work spans biochemistry, immunology, and nanomedicine, highlighted by numerous publications on nanosensors, therapeutic nanoparticles, and drug delivery advancements. Dr. Mohammadzadeh is also skilled in statistical analysis, technical writing, and communication. She aims to revolutionize healthcare through cutting-edge pharmaceutical nanotechnology. 📚💊

 

Publication Profile

Professional Background

Dr. Vahideh Mohammadzadeh is currently pursuing her Ph.D. in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research primarily focuses on advancing drug delivery systems, particularly through nanotechnology. She specializes in the formulation of nanoliposomes and other nanostructures like micelles and polymers for targeted therapy in cancer and ocular diseases. Dr. Mohammadzadeh has extensive experience in conducting in-vitro biochemical and immunological assays, including MTT assay and HPLC analysis. Her work is underscored by a prolific publication record encompassing topics such as nanosensors, therapeutic nanoparticles, and innovative drug formulations. 📊🔬

Education

Ph.D., Pharmaceutical Nanotechnology, Mashhad University of Medical Sciences, 2018-2024

M.Sc., Toxicology, Mashhad University of Medical Sciences, 2014-2017

B.Sc., Biology

Research Focus

Dr. Vahideh Mohammadzadeh’s research primarily focuses on advancing drug delivery systems in cancer therapy through innovative nanotechnologies. Her work spans the development and characterization of nanoliposomes, polymeric micelles, and other nanostructures to enhance the targeted delivery of therapeutic agents for cancer and ocular diseases. She explores novel formulations like liposomes and plant-based nanoparticles to optimize drug efficacy while minimizing side effects. Dr. Mohammadzadeh’s research also delves into nanosensors for biomolecule detection and the biological synthesis of nanoparticles for cytotoxicity studies. Her contributions aim to revolutionize healthcare through cutting-edge nanomedicine solutions. 🌟🔬

 

Publication Top Notes

  • Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination 📄 Citations: 14 | Cited by: Jaafari, M.R. et al. | Year: 2023
  • Plant Gel-Mediated Synthesis of Gold-Coated Nanoceria Using Ferula gummosa: Characterization and Estimation of Its Cellular Toxicity toward Breast Cancer Cell Lines 📄 Citations: 14 | Cited by: Sarafraz Ardakani, M.R. et al. | Year: 2023
  • Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering 📄 Citations: 22 | Cited by: Simal-Gandara, J. et al. | Year: 2023
  • Correction to: New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases 📄 Citations: 1 | Cited by: Qindeel, M. et al. | Year: 2022
  • Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update 📄 Citations: 21 | Cited by: Sibuh, B.Z. et al. | Year: 2022
  • Fluorescent-based nanosensors for selective detection of a wide range of biological macromolecules: A comprehensive review 📄 Citations: 106 | Cited by: Díez-Pascual, A.M. et al. | Year: 2022
  • Applications of plant-based nanoparticles in nanomedicine: A review 📄 Citations: 84 | Cited by: Varma, R.S. et al. | Year: 2022
  • Biological synthesis and characterization of gold nanoparticles using Verbascum speciosum Schrad. and cytotoxicity properties toward HepG2 cancer cell line 📄 Citations: 35 | Cited by: Nadaf, M. et al. | Year: 2022
  • Theranostic advances of bionanomaterials against gestational diabetes mellitus: A preliminary review 📄 Citations: 24 | Cited by: Thakur, V.K. et al. | Year: 2021

 

Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Posted on by ScienceFather

Dr. Xintian Shao | Pharmaceutical Science Award | Best Researcher Award

Dr. Xintian Shao, Shandong First Medical University & Shandong Academy of Medical Sciences, China

Dr. Xintian Shao earned her PhD in Microbiology and Biochemical Pharmacy from Shandong University, China, under the guidance of Prof. Peixue Ling. She expanded her expertise as a Visiting Scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Currently serving as an Associate Professor at Shandong First Medical University, her research has yielded 10 impactful publications and secured numerous grants. With two patents to her name, she’s been honored with prestigious awards including the Shandong Medical Science and Technology Award and the Science and Technology Award of Shandong Pharmaceutical Association.

 

Publication Profile 

Scopus

Education and Academic Achievements 📚🏅

Dr. Xintian Shao completed her PhD in Microbiology and Biochemical Pharmacy at the School of Pharmacy, Shandong University, China, under the guidance of Prof. Peixue Ling. She further enriched her expertise as a visiting scholar in Cancer Biology at the University of Cincinnati, USA, mentored by Prof. Jiajie Diao. Her prolific research has resulted in 10 publications, including notable contributions to journals such as Advanced Drug Delivery Reviews and Advanced Science. With multiple patents and prestigious grants to her credit, she has earned recognition including the Shandong Medical Science and Technology Award (2021) and the Science and Technology Award of Shandong Pharmaceutical Association (2022).

Work Experience 💼

Dr. Xintian Shao has served as an Associate Professor at the School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, China. Her role involves not only teaching and mentorship but also continued research contributions in her field.

Research Focus

Dr. Xintian Shao’s research primarily focuses on subcellular imaging and targeted drug delivery systems. Her work delves into the intricate dynamics of organelle interactions, particularly within mitochondria and lysosomes, employing cutting-edge super-resolution imaging techniques. She explores novel methods for visualizing drug molecules within living organisms, enhancing our understanding of drug distribution and efficacy. With a keen interest in membrane biology and organelle-specific targeting, her contributions shed light on fundamental cellular processes and hold promise for advancements in drug delivery and therapeutics.

Publication Top Notes 

  1. “Single-organelle localization-based super-resolution imaging for subcellular molecules micro-dynamics” by Fang, G. et al., Coordination Chemistry Reviews, 2024.
  2. “Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms” by Sun, T. et al., Acta Pharmaceutica Sinica B, 2024.
  3. “Mitochondrial nucleoid condensates drive peripheral fission through high membrane curvature” by Chen, Q. et al., Cell Reports, 2023.
    Cited by: 1
  4. “Graphene Oxide Nanosheets Induce Mitochondrial Fragmentation by Cutting through Membrane” by Shao, X. et al., ACS Materials Letters, 2023.
    Cited by: 4
  5. “Subcellular visualization: Organelle-specific targeted drug delivery and discovery” by Shao, X. et al., Advanced Drug Delivery Reviews, 2023.
    Cited by: 7
  6. “Recent advances in fluorescent probes of peroxynitrite: Structural, strategies and biological applications” by Sun, J. et al., Theranostics, 2023.
    Cited by: 8
  7. “Single Image Capture of Bioactive Ion Crosstalk within Inter-Organelle Membrane Contacts at Nanometer Resolution” by Fang, G. et al., Small Methods, 2022.
    Cited by: 8
  8. “Lysosome-Targeted Biosensor for the Super-Resolution Imaging of Lysosome–Mitochondrion Interaction” by Wang, H. et al., Frontiers in Pharmacology, 2022.
    Cited by: 4
  9. “Super-resolution image-based tracking of drug distribution in mitochondria of a label-free naturally derived drug molecules” by Wei, Y. et al., Chemical Engineering Journal, 2022.
    Cited by: 19
  10. “Prefused lysosomes cluster on autophagosomes regulated by VAMP8” by Chen, Q. et al., Cell Death and Disease, 2021.
    Cited by: 24